Sleep Disruption in Older Adults: Looking Beyond Sleeping Pills

As patients age, restful sleep often becomes elusive, and many want to turn to sleeping pills for relief. However, persistent insomnia in older adults may indicate something deeper. Specifically, a hormone imbalance. Recognizing when hormones are causing sleep disruption helps providers offer more effective treatment. 

Pellecome was founded by Dr. Enrique Jacome, a board-certified OB-GYN. He has been a respected leader in hormone therapy since 1995. Through Pellecome, he created a system that helps healthcare providers address the root causes of certain symptoms, including sleep disruption, using bioidentical hormone replacement therapy (BHRT).

How to Spot a Hormonal Cause of Insomnia

Sleep troubles caused by hormonal imbalance have distinct signs. Older patients who frequently awaken at night or struggle to fall asleep despite feeling exhausted may be dealing with:

• Night sweats
• Hot flashes
• Anxiety
• Restlessness

During menopause, declining estrogen and progesterone can disrupt sleep regulation.¹ In men, reduced testosterone can interrupt sleep patterns and increase cortisol, the stress hormone, contributing to persistent insomnia.²

Why Hormones Can Be a Better Option Than Sleeping Pills

While sleeping pills offer temporary relief, they come with risks such as dependency, cognitive impairment, and diminishing effectiveness over time. They can even lead to an increased risk of mortality.³

Rather than masking symptoms, treating the underlying hormonal imbalance with BHRT can provide lasting improvement in sleep quality. BHRT pellets offer controlled hormone release, leading to stable sleep patterns and overall better patient outcomes without the side effects of pharmaceuticals.^4,5

What Makes Pellecome the Best Choice for Providers?

Not all BHRT providers are equal. Pellecome distinguishes itself through innovative pellet technology and robust provider support. Pellecome’s patented Re3 Advanced Delivery System ensures precise pellet insertion, reducing bruising, discomfort, and inflammation compared to competitors. 

Pellecome providers pay no procedural fees or contracts, receive extensive training, ongoing clinical support, and marketing resources designed to help practices thrive. Pellecome ensures reliable, consistent hormone delivery, helping your patients experience genuine relief.

Grow Your Practice With Pellecome BHRT

Integrating BHRT into your practice can attract patients actively seeking non-pharmaceutical sleep solutions. By offering Pellecome’s BHRT, you can treat the cause of insomnia and differentiate your practice as a trusted source of comprehensive care.

If you are ready to explore hormone therapy to potentially help your patients sleep better, contact Pellecome directly at 888-773-9969.

1. Morssinkhof MWL, van Wylick DW, Priester-Vink S, van der Werf YD, den Heijer M, van den Heuvel OA, et al. Associations between sex hormones, sleep problems and depression: A systematic review. Neurosci Biobehav Rev [Internet]. 2020;118:669–80. Available from: http://dx.doi.org/10.1016/j.neubiorev.2020.08.006 
2. Wittert G. The relationship between sleep disorders and testosterone in men. Asian J Androl [Internet]. 2014;16(2):262–5. Available from: http://dx.doi.org/10.4103/1008-682X.122586 
3. Sun Y, Tsai MK, Wen CP. Association of sleep duration and sleeping pill use with mortality and life expectancy: A cohort study of 484,916 adults. Sleep Health [Internet]. 2023;9(3):354–62. Available from: http://dx.doi.org/10.1016/j.sleh.2023.01.017 
4. Lee J, Han Y, Cho HH, Kim MR. Sleep disorders and menopause. J Menopausal Med [Internet]. 2019;25(2):83–7. Available from: http://dx.doi.org/10.6118/jmm.19192 
5. Shigehara K, Konaka H, Sugimoto K, Nohara T, Izumi K, Kadono Y, et al. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea. Aging Male [Internet]. 2018;21(2):99–105. Available from: http://dx.doi.org/10.1080/13685538.2017.1378320